Multiple analytical approaches reveal distinct gene-environment interactions in smokers and non smokers in lung cancer

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Ihsan, Rakhshan ^a   Chauhan, Pradeep Singh ^a   Mishra, Ashwani Kumar ^a   Yadav, Dhirendra Singh ^a   Kaushal, Mishi ^a   Sharma, Jagannath Dev ^b   Zomawia, Eric ^c   Verma, Yogesh ^d   Kapur, Sujala ^a   Saxena, Sunita ^a  

^a SAFDARJUNG HOSPITAL   (India)

^b Dr Bhubaneswar Borooah Cancer Institute   (India)

^c Aizawl Civil Hospital   (India)

^d Sir Thutob Namgyal Memorial Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYTOCHROME P450 1A1; EPOXIDE HYDROLASE; EPOXIDE HYDROXYLASE 1; GENOMIC DNA; GLUTATHIONE TRANSFERASE P1; HISTIDINE; ISOLEUCINE; SULFOTRANSFERASE 1A1; TYROSINE; UNCLASSIFIED DRUG; VALINE; EPHX1 PROTEIN, HUMAN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BETEL NUT; CANCER RISK; CASE CONTROL STUDY; CLASSIFICATION AND REGRESSION TREE; CONTROLLED STUDY; ENTROPY; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HETEROZYGOTE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; MULTIFACTOR DIMENSIONALITY REDUCTION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKELESS TOBACCO; SMOKING; STATISTICAL ANALYSIS; XENOBIOTIC METABOLIZING GENE; COMPARATIVE STUDY; DATA MINING; GENETIC PREDISPOSITION; GENETICS; LABORATORY DIAGNOSIS; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; PROBABILITY; REPRODUCIBILITY; SAMPLE SIZE; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; CYTOCHROME P-450 CYP1A1; DATA MINING; EPOXIDE HYDROLASES; FALSE POSITIVE REACTIONS; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIFACTOR DIMENSIONALITY REDUCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROBABILITY; REPRODUCIBILITY OF RESULTS; SAMPLE SIZE; SMOKING; STATISTICS, NONPARAMETRIC;

EID: 83655198352     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029431     Document Type: Article

References (57)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global Cancer Statistics. CA Cancer J Clin 61: 69-90.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer. Available: http://globocan.iarc.fr Accessed 20 June 2011.
3. Zomawia E, Zohmingthanga J, Lalchhanhimi, Zonunsiama, Saia, (2010) Population Based Cancer Registry, Mizoram. Three year report of the Population Based Cancer Registries, 2006-2008. First Report of 20 PBCRs in India. National Cancer Registry Programme, Indian Council of Medical Research, Bangalore. pp. 330-380 In.:.
4. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, et al. (2001) Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69 (1): 138-147.
5. Liu L, Wu C, Wang Y, Zhong R, Wang F, et al. (2011) Association of candidate genetic variations with gastric cardia adenocarcinoma in Chinese population: a multiple interaction analysis. Carcinogenesis 32 (3): 336-342.
6. World Health Organization (1998) Guidelines for controlling and monitoring the tobacco epidemic. Geneva WHO.
7. Nazar-Stewart V, Vaughan TL, Stapleton P, Van Loo J, Nicol-Blades B, et al. (2003) A population-based study of glutathione S-transferase M1, T1 and P1 genotypes and risk for lung cancer. Lung Cancer 40: 247-258.
8. Sparks R, Ulrich C M, Bigler J, Tworoger SS, Yasui Y, et al. (2004) UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res 6 (5): R488-498.
9. Nisa H, Kono S, Yin G, Toyomura K, Nagano J, et al. (2010) Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study BMC Cancer 10: 274.
10. Zhao M, Lewis R, Gustafson DR, Wen WQ, Cerhan JR, et al. (2001) No apparent association of GSTP1 A(313)G polymorphism with breast cancer risk among postmenopausal Iowa women. Cancer Epidemiol Biomarkers Prev 10 (12): 1301-1302.
11. Smith CA, Harrison DJ, (1997) Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 50 (9078): 630-633.
12. Sam SS, Thomas V, Reddy SK, Surianarayanan G, Candrasekaran A, (2008) CYP1A1 polymorphisms and the risk of upper aerodigestive tract cancers in an Indian population. Head Neck 30 (12): 1566-1574.
13. Steinberg D, Colla P, (1997) CART- classification and regression trees. San Diego Salford Systems.
14. Hahn LW, Ritchie MD, Moore JH, (2003) Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19 (3): 376-382.
15. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N, (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96 (6): 434-442.
16. Demsar J, Zupan B, (2004) Orange: From Experimental Machine Learning to Interactive Data Mining. White Paper (www.ailab.si/orange), Faculty of Computer and Information Science, University of Ljublijana, Ljublijana, Slovenia. Omnipress, Madison, WI.
17. Jakulin A, Bratko I, (2003) Analyzing attribute dependencies. In: Lavrac N, Gamberger D, Blockeel H, Todorovski L, editors. Lecture Notes in Computer Science Vol. 2838, Springer-Verlag. Croatia pp. 229-240.
18. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ, (1994) Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3 (3): 421-428.
19. Benhamou S, Reinikainen M, Bouchardy C, Dayer P, Hirvonen A, (1998) Association between lung cancer and microsomal epoxide hydrolase genotype. Cancer Res 58 (23): 5291-5293.
20. London SJ, Smart J, Daly AK, (2000) Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County. Lung Cancer 28 (2): 147-155.
21. Zhou W, Liu G, Thurston SW, Xu LL, Miller DP, et al. (2002) Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Cancer Epidemiol Biomarkers Prev 11 (1): 15-21.
22. Lancaster JM, Brownlee HA, Bell DA, Futreal PA, Marks JR, et al. (1996) Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog 17: 160-162.
23. Ihsan R, Chattopadhyay I, Phukan R, Mishra AK, Purkayastha J, et al. (2010) Role of epoxide hydrolase 1 gene polymorphisms in esophageal cancer in a high-risk area in India. J Gastroenterol Hepatol 25 (8): 1456-1462.
24. Glatt H, (1997) Sulfation and sulfotransferases 4: bioactivation of mutagens via sulfation. FASEB J 11 (5): 314-321.
25. Nowell SA, Ozawa S, Ambrosone CB, MacLeod SL, Kadlubar FF, et al. (2000) Relationship of SULT1A1 genotype to sulfotransferase activity phenotype in platelet cytosol: effect of genotype on heterocyclic amine activation. Proc Am Assoc Cancer Res 41: 551.
26. Jones AL, Roberts RC, Coughtrie MW, (1993) The human phenolsulphotransferase polymorphism is determined by the level of expression of the enzyme protein. Biochem J 296, 287-290.
27. Denissenko MF, Pao A, Tang M, Pfeifer GP, (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspot in p53. Science 274 (5286): 430-432.
28. Wong CF, Liyou N, Leggett B, Young J, Johnson A, et al. (2002) Association of the SULT1A1 R213H polymorphism with colorectal cancer. Clin. Exp. Pharmacol. Physiol 29: 754-758.
29. Steiner M, Bastian M, Schulz WA, Pulte T, Franke KH, et al. (2000) Phenol sulfotransferase SULT1A1 polymorphism in prostate cancer: lack of association. Arch. Toxicol 74: 222-225.
30. Zheng W, Xie D, Cerhan JR, Sellers TA, Wen W, et al. (2001) Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol. Biomarkers Prev 10: 89-94.
31. Bamber DE, Fryer AA, Strange RC, Elder JB, Deakin M, et al. (2001) Phenol sulfotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer. Pharmacogenetics 11: 679-685.
32. Kotnis A, Kannan S, Sarin R, Mulherkar R, (2008) Case-control study and meta-analysis of SULT1A1 Arg213His polymorphism for gene, ethnicity and environment interaction for cancer risk. British Journal of Cancer 99 (8): 1340-1347.
33. Landi MT, Bertazzi PA, Shields PG, Clark G, Lucier GW, et al. (1994) Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics 4: 242-246.
34. Cosma G, Crofts F, Taioli E, Toniolo P, Garte S, (1993) Relationship between genotype and function of the human CYP1A1 gene. J Toxicol Environ Health 40: 309-316.
35. Taioli E, Ford J, Trachman J, Li Y, Demopoulos R, et al. (1998) Lung cancer risk and CYP1A1 genotype in African Americans. Carcinogenesis 19 (5): 813-817.
36. Lee KM, Kang D, Clapper ML, Ingelman-Sundberg M, Ono-Kihara M, et al. (2008) CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations. Cancer Epidemiol Biomarkers Prev 17 (5): 1120-1126.
37. Taioli E, Gaspari L, Benhamou S, Boffetta P, Brockmoller J, et al. (2003) Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int J Epidemiol 32 (1): 60-63.
38. Le Marchand L, Guo C, Benhamou S, Bouchardy C, Cascorbi I, (2003) Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control 14 (4): 339-346.
39. San Jose C, Cabanillas A, Benitez J, Carrillo JA, Jimenez M, et al. (2010) CYP1A1 gene polymorphisms increase lung cancer risk in a high incidence region of Spain: a case control study. BMC Cancer 10: 463-469.
40. Yoshida K, Osawa K, Kasahara M, Miyaishi A, Nakanishi K, et al. (2007) Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking. Asian Pac J Cancer Prev 8 (3): 438-444.
41. Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J, (1997) Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 272 (15): 10004-10012.
42. Cote ML, Chen W, Smith DW, Benhamou S, Bouchardy C, et al. (2009) Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC review. Am J Epidemiol 169 (7): 802-814.
43. Coles B, Yang M, Lang NP, Kadlubar FF, (2000) Expression of hGSTP1 alleles in human lung and catalytic activity of the native protein variants towards 1-chloro-2,4-dinitrobenzene, 4-vinylpyridine and (+)-anti benzo[a]pyrene-7,8-diol-9,10-oxide. Cancer Lett 156 (2): 167-175.
44. Ketterer B, Harris JM, Talaska G, Meyer DJ, Pemble SE, et al. (1992) The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ Health Perspect 98: 87-94.
45. Zhong S, Howie AF, Ketterer B, Taylor J, Hayes JD, et al. (1991) Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis 12: 1533-1537.
46. Jin Y, Xu H, Zhang C, Kong Y, Hou Y,et al. (2010) Combined effects of cigarette smoking, gene polymorphisms and methylations of tumor suppressor genes on non small cell lung cancer: a hospital-based case-control study in China. BMC Cancer 10: 422.
47. Nazar-Stewart V, Motulsky AG, Eaton DL, White E, Hornung SK, et al. (1993) The glutathione S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res 53: s2313-s2318.
48. Jain M, Kumar S, Rastogi N, Lal P, Ghoshal UC, et al. (2006) GSTT1, GSTM1 and GSTP1 and genetic polymorphisms and interaction with tobacco, alcohol and occupational exposure in esophageal cancer patients from North India. Cancer Lett 242 (1): 60-67.
49. Rouissi K, Ouerhani S, Hamrita B, Bougatef K, Marrakchi R, et al. (2011) Smoking and Polymorphisms in Xenobiotic Metabolism and DNA Repair Genes are Additive Risk Factors Affecting Bladder Cancer in Northern Tunisia. Pathol Oncol Res 17 (4): 879-886.
50. Chen K, Jiang QT, Ma XY, Yao KY, Leng SG, et al. (2004) Associations between genetic polymorphisms of glutathione S-transferase M1 and T1, smoking and susceptibility to colorectal cancer: a case-control study. Zhonghua Zhong Liu Za Zhi 26 (11): 645-648.
51. Buch SC, Notani PN, Bhisey RA, (2002) Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis 23 (5): 803-807.
52. Wen CP, Tsai MK, Chung WS, Hsu HL, Chang YC, et al. (2010) Cancer risks from betel quid chewing beyond oral cancer: a multiple-site carcinogen when acting with smoking. Cancer Causes Control 9: 1427-1435.
53. Awang MN, (1988) Betel quid and oral carcinogenesis. Singapore Med J 29 (6): 589-593.
54. Ihsan R, Devi TR, Yadav DS, Mishra AK, Sharma J, et al. (2011) Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North East India. DNA Cell Biol 30 (3): 163-171.
55. Kaushal M, Mishra AK, Raju BS, Ihsan R, Chakraborty A, et al. (2010) Betel quid chewing as an environmental risk factor for breast cancer. Mutat Res 703 (2): 143-148.
56. Jain M, Tilak AR, Upadhyay R, Kumar A, Mittal B, (2008) Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer. Toxicol Appl Pharmacol 230 (2): 247-251.
57. Yadav DS, Devi TR, Ihsan R, Mishra AK, Kaushal M, et al. (2010) Polymorphisms of glutathione-S-transferase genes and the risk of aerodigestive tract cancers in the Northeast Indian population. Genet Test Mol Biomarkers 14 (5): 715-723.